Market Leadership Qunol is the #1 CoQ10 brand in the US and is positioned as the #1 Cardiologist-recommended form of CoQ10, backed by enhanced absorption formulations. The portfolio spans softgels, liquids, and chewables, with Turmeric added in 2018 and ambitions to become the top turmeric brand. This leadership can fuel co-branding, retailer promos, and cross-sell opportunities across related wellness products.

Channel Reach Products are sold through Costco, Walmart, Amazon, Walgreens, CVS and other major retailers, plus direct sales via Qunol.com. This omni-channel footprint enables retailer exclusives, private-label discussions, and bundled promotions that boost reach and repeat purchase.

Strategic Partnering Sanofi acquired Qunol Turmeric Gummies in 2023, signaling potential for large-scale distribution and strategic partnerships. Monitor for enterprise partnerships, licensing deals, or co-branded initiatives that can accelerate growth beyond core DTC and mass retailers.

Quality Focus A recall of Turmeric Gummies batches in early 2026 highlights QA considerations; emphasize robust testing and traceability to reassure retailers and distributors, while highlighting ongoing quality improvements as a selling point for health-focused customers and institutional buyers.

Growth Opportunities The product suite aligns with wellness and healthy aging trends, supported by diverse formats including a recent Instant Turmeric Drink Mix. With a strong e-commerce setup and digital marketing tools, opportunities exist in clinics, gyms, senior living programs, and partnerships with healthcare providers for cross-category wellness bundles.